These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27232956)

  • 21. Mechanism of decreased susceptibility for Gram-negative bacteria and synergistic effect with ampicillin of indole-3-carbinol.
    Sung WS; Lee DG
    Biol Pharm Bull; 2008 Sep; 31(9):1798-801. PubMed ID: 18758080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.
    Han HM; Gopal R; Park Y
    Amino Acids; 2016 Feb; 48(2):505-22. PubMed ID: 26450121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyxins: a review of the current status including recent developments.
    Kwa AL; Tam VH; Falagas ME
    Ann Acad Med Singap; 2008 Oct; 37(10):870-83. PubMed ID: 19037522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining.
    Li YX; Zhong Z; Zhang WP; Qian PY
    Nat Commun; 2018 Aug; 9(1):3273. PubMed ID: 30115920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates.
    Mohamed YF; Abou-Shleib HM; Khalil AM; El-Guink NM; El-Nakeeb MA
    Braz J Microbiol; 2016; 47(2):381-8. PubMed ID: 26991296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics.
    Vaara M
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of membrane targeting antibiotics.
    Epand RM; Walker C; Epand RF; Magarvey NA
    Biochim Biophys Acta; 2016 May; 1858(5):980-7. PubMed ID: 26514603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics.
    Mogi T; Kita K
    Cell Mol Life Sci; 2009 Dec; 66(23):3821-6. PubMed ID: 19701717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers.
    Lam SJ; O'Brien-Simpson NM; Pantarat N; Sulistio A; Wong EH; Chen YY; Lenzo JC; Holden JA; Blencowe A; Reynolds EC; Qiao GG
    Nat Microbiol; 2016 Sep; 1(11):16162. PubMed ID: 27617798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel antimicrobial agents against multi-drug-resistant gram-negative bacteria: an overview.
    Karras G; Giannakaki V; Kotsis V; Miyakis S
    Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):175-81. PubMed ID: 23061790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
    Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
    Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial activity of cecropins.
    Moore AJ; Beazley WD; Bibby MC; Devine DA
    J Antimicrob Chemother; 1996 Jun; 37(6):1077-89. PubMed ID: 8836811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of bactericidal action and resistance of polymyxins for Gram-positive bacteria.
    Yin J; Meng Q; Cheng D; Fu J; Luo Q; Liu Y; Yu Z
    Appl Microbiol Biotechnol; 2020 May; 104(9):3771-3780. PubMed ID: 32157424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentamidine sensitizes FDA-approved non-antibiotics for the inhibition of multidrug-resistant Gram-negative pathogens.
    Wu C; Xia L; Huang W; Xu Y; Gu Y; Liu C; Ji L; Li W; Wu Y; Zhou K; Feng X
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1771-1779. PubMed ID: 32242313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria.
    Choi H; Lee DG
    Res Microbiol; 2012 Jul; 163(6-7):479-86. PubMed ID: 22705395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial peptides and the outer membranes of gram-negative bacilli.
    Hancock RE
    J Med Microbiol; 1997 Jan; 46(1):1-3. PubMed ID: 9003734
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
    Domalaon R; Idowu T; Zhanel GG; Schweizer F
    Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.